Login to Your Account

Oxford GlycoSciences Considers Interest From Celltech, Others

By Nuala Moran

Wednesday, February 19, 2003
LONDON - Celltech Group plc has refused to comment on reports that it is preparing to make a cash bid for Oxford GlycoSciences plc, undermining the agreed-to all-share takeover offer made by Cambridge Antibody Technology Group plc on Jan. 23. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription